Halladay Benjamin
CIK 0001953943
Chief Financial Officer
Filings
14
Latest Mar 18, 2026
Issuers covered
1
Showing
14 of 14
Page 1
Track record
10 of 10 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 10 | 70% | +4.1% | +10.3% | +39.9% | -69.4% |
| 90 days | 9 | 56% | -12.7% | +25.8% | +57.0% | -155.0% |
| 180 days | 8 | 38% | -72.6% | -43.2% | +52.4% | -246.8% |
| 365 days | 5 | 0% | -67.6% | -58.9% | -30.8% | -114.7% |
Issuers
Companies where Halladay Benjamin has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ESPR | Esperion Therapeutics, Inc. | 14 | Mar 18, 2026 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|